Effectiveness of Nutritional Products to Treat Moderate Acute Malnutrition
NCT ID: NCT01898871
Last Updated: 2013-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
81 participants
INTERVENTIONAL
2012-02-29
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Relative Effectiveness of Two Feeding Interventions for the Treatment of Moderate Acute Malnutrition
NCT01097889
Treating Moderate Malnutrition in 6-24 Months Old Children
NCT01115647
Effectiveness Comparison of Three Supplementary Foods in the Treatment of Moderate Acute Malnutrition
NCT00998517
Acceptability of a Microbiome-directed Food in Young Children With Acute Malnutrition
NCT05551819
Feasibility and Acceptability of a Soy-fiber-maize Complementary Food in Malawi.
NCT03385590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ready to Use Suplementary Food (RUSF)
A daily ration of 40 kcal/kg of body weight during 56 days
A daily ration of 40 kcal/kg of body weight during 56 days
On enrollment, children were examined by a pediatrician to assess their health status and they were de-wormed with one tablet of Mebendazole 500 mg.
Corn Soya Blend (CSB+)
A daily ration of 40 kcal/kg of body weight during 56 days
A daily ration of 40 kcal/kg of body weight during 56 days
On enrollment, children were examined by a pediatrician to assess their health status and they were de-wormed with one tablet of Mebendazole 500 mg.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A daily ration of 40 kcal/kg of body weight during 56 days
On enrollment, children were examined by a pediatrician to assess their health status and they were de-wormed with one tablet of Mebendazole 500 mg.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Weight-for-height between -3 and -2 z-scores without edema
* Good appetite
* Stable clinical conditions
Exclusion Criteria
* Presence of bilateral pitting edema
* Unstable clinical conditions
* Not showing appetite
6 Months
59 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Atomic Energy Agency
OTHER_GOV
Centre for Food and Nutrition Research, Yaounde
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Medoua Nama Gabriel
Deputy Head of Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabriel Medoua Nama, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Centre for Food and Nutrition Research, IMPM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Evodoula Health District
Évodoula, , Cameroon
Biyem Assi District Centre
Yaoundé, , Cameroon
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMR6010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.